US pharma major AstraZeneca today released high-level results from the Cardiac Amyloid Reaching for Extended Survival (CARES) ...

The UK government’s new life sciences plan has been met with skepticism by the pharmaceutical industry, which says the ...

The US regulator has launched a new national initiative to help Medicaid programs fund gene therapies for sickle cell disease ...

On Tuesday, the day new global data reveal that childhood vaccine coverage has stalled and deadly disease outbreaks are ...

Sino Biopharmaceutical (HKEX: 1177) is acquiring the remaining stake in Chinese biotech LaNova Medicines, setting the stage ...

The US Food and Drug Administration approved, the first rapid-acting interchangeable biosimilar product, Kirsty (insulin ...

Japanese drugmaker JCR Pharmaceuticals has entered into a joint collaboration, option and license agreement with US biotech Acumen Pharmaceuticals to develop a novel therapeutic candidate for the ...

China-based Jiangsu Hengrui Pharma and US start-up Kailera Therapeutics, which is advancing a broad pipeline of ...

The USA's Institute for Clinical and Economic Review (ICER) has released a Final Evidence Report assessing the comparative ...

Russia will begin commercial production of a new anticancer vaccine, which massive supplies for the needs of domestic ...

In the USA, the 340B hospital markup program cost state and federal taxpayers an estimated $6.5 billion per year due to lost ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Ekterly (sebetralstat) 0for the ...